Ming Jin

Q: What is Ming Jin email address?

Email Ming Jin at mjin@biolegend.com. This email is the most updated Ming Jin email found in 2026.

Q: How to contact Ming Jin?

To contact Ming Jin send an email to mjin@biolegend.com. (updated on November 05, 2024)

Principal Scientist, Cellular Process Development at ElevateBio | Newton, Massachusetts, United States

About Ming Jin

Ming Jin serves as a Principal Scientist in Cellular Process Development at ElevateBio, where he leverages over a decade of expertise in the biotechnology and pharmaceutical industries to drive innovation in cell therapy manufacturing. His role involves strategic collaboration with both internal teams and external partners to design and oversee cellular process development studies. This includes the optimization of manufacturing processes for a diverse portfolio of cellular therapies, notably multiple CAR (Chimeric Antigen Receptor) and TCR (T Cell Receptor) therapies. Ming's extensive background in cGMP (current Good Manufacturing Practice) settings equips him with the necessary skills to ensure that all processes meet stringent regulatory standards while maintaining high-quality product output.

In addition to his technical prowess, Ming is committed to fostering talent within his team. He actively hires and manages key personnel, providing strategic leadership and mentorship to junior staff, which is crucial for building a robust pipeline of skilled professionals in the rapidly evolving field of cell therapy. His expertise in laboratory management, aseptic techniques, and analytical methods development plays a vital role in enhancing manufacturing process improvement initiatives. Furthermore, his research background in aging and stem cell research informs his approach to product development, enabling him to contribute valuable insights into the complexities of cellular differentiation and therapeutic efficacy. At ElevateBio, Ming Jin is not just a scientist; he is a catalyst for innovation, dedicated to advancing the frontiers of cellular therapies and improving patient outcomes.

Ming Jin Work